Low Bone Mass Secondary to Antipsychotic Medications

Saudi Journal of Medicine & Medical Sciences
Abdallah S Al-OmranWaleed K Shihada

Abstract

Antipsychotic medications are known to cause low bone mass. The objective of this study was to assess the prevalence of osteopenia and osteoporosis secondary to patients taking antipsychotic medications. This prospective study included 175 patients taking antipsychotic medications and attending the psychiatric clinics at the King Fahd Hospital of the University, Al-Khobar, Saudi Arabia. Demographic data, antipsychotic medications, type, and duration of administration of medication were collected. All patients had bone mass measurement using dual energy X-ray (DXA) absorptiometry. Patients were divided into 5-year groups, from ≤35 to ≥51 years. The data were entered in the database and analyzed using SPSS Inc version 20. The average age of patients was 40.75 ± 7.16 years (range: 26-56 years), there were 120 (82.8%) males and 25 (17.2%) females. Our results indicate that the average duration of anti-psychotic medication use was 8.45 ± 5.4 years. DXA of the hip revealed that 25 (14.2%) patients were osteoporotic and 104 (59.42%) were osteopenic, while on the basis of the T-score of the lumbar spine, 77 (44%) patients were osteoporotic and 80 (45.7%) were osteopenic. On the basis of the spinal bone mineral density (BMD), 89.7% had ...Continue Reading

Methods Mentioned

BETA
X-ray

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Lung India : Official Organ of Indian Chest Society
Rakesh K GuptaMir Sadat-Ali
Saudi Medical Journal
Mir Sadat-AliAbdallah S Al-Omran
Ginecología y obstetricia de México
Ma Guzmán IbarraMiriam García Ruíz Esparza
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
R Kullenberg, J A Falch
© 2022 Meta ULC. All rights reserved